New characteristics of aggressive prostate cancer identified
February 12, 2026
For the first time ever, NTNU researchers have identified new characteristics of aggressive prostate cancer.
For the first time ever, NTNU researchers have identified new characteristics of aggressive prostate cancer.
Researchers led by Min Zhang and Dabao Zhang of the University of California, Irvine’s Joe C. Wen School of Population & Public Health have created the most detailed maps to date showing how genes causally regulate one another across different types of brain cells affected by Alzheimer’s disease.
Researchers have developed a highly sensitive light-based sensor that can detect extremely low concentrations of cancer biomarkers in the blood.
Cancer researchers working on immunotherapies have made a big discovery: SLAMF6, a molecule on the surface of immune cells that prevents T cells from effectively attacking tumors—and, in mice, they’ve found a way to neutralize it.
Researchers have identified and characterized a previously unknown cellular barrier in the brain, which sheds new light on how the brain is protected from the rest of the body.
While other drugs clear existing plaques, levetiracetam prevents production of toxic amyloid beta peptides
Driven by overuse and misuse of antibiotics, drug-resistant infections are on the rise, while development of new antibacterial tools has slowed.
BVI announced the first successful U.S. implantations of the FDA-approved FineVision HP hydrophobic trifocal intraocular lens (IOL).
A wearable biosensor developed by Washington State University researchers could improve wireless glucose monitoring for people with diabetes, making it more cost-effective, accurate, and less invasive than current models.
Researchers have developed a new artificial intelligence-based approach for detecting fatty deposits inside coronary arteries using optical coherence tomography (OCT) images.